FDA Investigator Ziyang Su, PhD
Ziyang Su, PhD has inspections in 3 countries as of 11 Oct 2023. Ziyang Su, PhD has collaborated with a combinined 1317 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Ireland,
Germany,
United States of America
Co-Investigator(s):
Amy C Jordan,
Amy N Chen,
Anh M Lac,
Anita Narula, PhD,
Ann L Demarco,
Azza Talaat,
Bo Chi, PhD,
Brenda W Uratani, PhD,
Calvin B Koerner,
Christopher Downey, PhD,
Daryl A Dewoskin,
Diane L Raccasi,
Dien N Nguyen,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Edmund F Mrak, Jr,
Eliezar Ramos,
Erika V Butler,
Felix Maldonado,
Gene D Arcy,
Jacek Cieslak, PhD,
John D White,
Jose E Melendez, DDC,
Julie D Bringger,
Junho Pak,
Kalavati Suvarna, PhD,
Karen A Briggs,
Kathleen R Jones, PhD,
Kevin A Gonzalez,
Kurt A Brorson, PhD,
Laurel A Beer,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Maria Joselopez Barragan, PhD,
Mariza M Jafary,
Mark Brunswick, PhD,
Mark R Mcclain,
Mary E Storch,
Megan A Haggerty,
Michael Shanks, MS,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Monica Commerford, PhD,
Mra Munizn,
Nealie C Newberger,
Omotunde O Osunsanmi,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Robert D Tollefsen,
Robert W Jennings,
Rose M Ashley,
Sean R Marcsisin,
Stacey S Degarmo,
Steven Fong, MS, PhD,
Thuy T Nguyen, LCDR,
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Walter N Lange,
Wayne E Seifert,
William Hallett, PhD,
Yanming An, PhD,
Yetao Jin, PhD,
Zerita White,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Ziyang Su, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2019 | FDA 483 | Immunex Rhode Island Corporation - Form 483, 2019-04-19 |
August, 2017 | FDA 483 | MSD Ireland (Carlow) - Form 483, 2017-08-22 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more